Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.89 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.61 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2850174 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL15650877 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL31027022 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL1425246 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL9652482 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL9652475 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL1854806 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL1425249 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL1854805 | 1.00 | FAAH (0.89) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 | |
| SCHEMBL7875829 | 0.98 | FAAH (0.86) | FAAHSLC6A5SMN1; SMN2ASAH2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4138770-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| US-20220378677-A1 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | M. MUSTIX LTD (IL) | 2022-12-01 | — | — | US | claimed |
| US-20210379010-A1 | COMPOSITIONS COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF BIOFILM AND CONDITIONS ASSOCIATED WITH MICROBIAL, FUNGAL, BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-12-09 | — | — | US | claimed |
| WO-2021212404-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | HENKEL AG & CO. KGAA (DE) | 2021-10-28 | — | — | WO | claimed |
| EP-3873449-A1 | COMPOSITIONS COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF BIOFILM AND CONDITIONS ASSOCIATED WITH MICROBIAL, FUNGAL, BACTERIAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2021-09-08 | — | — | EP | claimed |
| WO-2021084543-A1 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | M. MUSTIX LTD (IL) | 2021-05-06 | — | — | WO | claimed |
| WO-2020242133-A1 | COMPOSITION FOR PREVENTING OR TREATING ASTHMA, RHINITIS OR CONJUNCTIVITIS, COMPRISING N-ACYL AMINO ACID AS ACTIVE INGREDIENT | 전북대학교 산학협력단 | 2020-12-03 | — | — | WO | claimed |
| CN-106109257-B | A kind of amino acid is without silicone oil shampoo | 南通安佳家生物科技有限公司 | 2018-06-26 | — | — | CN | claimed |
| CN-105675749-B | The analysis method of cocoyl amino acid surfactant carbochain composition | 广州天赐高新材料股份有限公司 | 2017-07-18 | — | — | CN | claimed |
| WO-2025022402-A1 | COMPOSITIONS AND METHODS FOR TREATING BEHAVIOR DISEASES | Ariel Scientific Innovations Ltd. (IL) | 2025-01-30 | — | — | WO | disclosed |
| CN-114289187-B | Bauxite flotation combined collector and preparation method thereof | 郑州大学 | 2024-01-26 | — | — | CN | disclosed |
| EP-4138770-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-20220378677-A1 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | M. MUSTIX LTD (IL) | 2022-12-01 | — | — | US | disclosed |
| US-20220110901-A1 | FATTY ACID AMIDES AND USES THEREOF IN THE TREATMENT OF NAUSEA | PARKER LINDA (CA) | 2022-04-14 | — | — | US | disclosed |
| EP-1827379-A2 | FORMULATIONS CONTAINING ALKYLPHOSPHOCHOLINES USING NOVEL NEGATIVE CHARGE CARRIERS | MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006042751-A2 | FORMULATIONS CONTAINING ALKYLPHOSPHOCHOLINES USING NOVEL NEGATIVE CHARGE CARRIERS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2006-04-27 | — | — | WO | disclosed |
| EP-0271816-B1 | CURABLE POLYESTER-MOULDING COMPOSITIONS | BASF Aktiengesellschaft (DE) | 1992-03-11 | — | — | EP | disclosed |
| US-4777195-A | Curable polyester molding materials | BASF AKTIENGESELLSCHAFT (DE) | 1988-10-11 | — | — | US | disclosed |
| EP-0271816-A2 | Curable polyester-moulding compositions | BASF Aktiengesellschaft (DE) | 1988-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220110901-A1 | FATTY ACID AMIDES AND USES THEREOF IN THE TREATMENT OF NAUSEA | FFAR2, FAAH, FABP2 | FAAH 2/4885SLC6A5 506/4885SMN1; SMN2 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.